Unravelling the Interplay between Metabolism, Gut Microbiome and Adaptive Immunity in Amyotrophic Lateral Sclerosis

Project Information

MegaALS

Grant agreement ID: 802091

DOI 10.3030/802091

EC signature date 30 October 2018

Start date 1 November 2018

End date 31 October 2024

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 1 499 196,00

EU contribution € 1 499 196,00

Coordinated by

KAROLINSKA INSTITUTET
Sweden

Publications

Non-peer reviewed articles (1)

Gut microbiome and amyotrophic lateral sclerosis ‐ a systematic review of current evidence

Author(s): Jiangwei Sun, Tingting Huang, Justine W. Debelius, Fang Fang
Published in: Journal of Internal Medicine, 2021, ISSN 0954-6820
Publisher: Blackwell Publishing Inc.
DOI: 10.1111/joim.13336

Peer reviewed articles (2)

Peripheral immune biomarkers and neurodegenerative diseases: A prospective cohort study with 20 years of follow‐up

Author(s): Solmaz Yazdani, Daniela Mariosa, Niklas Hammar, John Andersson, Caroline Ingre, Göran Walldius, Fang Fang
Published in: Annals of Neurology, Issue 86/6, 2019, Page(s) 913-926, ISSN 0364-5134
Publisher: John Wiley & Sons Inc.
DOI: 10.1002/ana.25614

Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis

Author(s): Caroline Ingre, Lin Chen, Yiqiang Zhan, Jet Termorshuizen, Li Yin, Fang Fang
Published in: Neurology, Issue 94/17, 2020, Page(s) e1835-e1844, ISSN 0028-3878
Publisher: Lippincott Williams & Wilkins Ltd.
DOI: 10.1212/wnl.0000000000009322

Thesis and dissertations (1)

Examining the correlation between regulatory T-cell and the progression of patients diagnosed with amyotrophic lateral sclerosis

Author(s): Tomas Wikström, Christina Seitz
Published in: 2020
Publisher: N/A